Roseline d’Oiron is a Clinician Investigator and Associate Director at the the Reference Centre for Haemophilia and Rare Congenital Bleeding Disorders at Bicêtre Hospital AP-HP and University of Paris-Saclay, France. She is also responsible for Specialist training for the master’s degree in haematology at University Paris VII. She is the current elected president of the Steering Committee of the FranceCoag Network, a national registry of bleeding disorders, a member of the European Haemophilia Consortium’s Medical and Scientific Advisory Group and a member of the Women and Bleeding Disorders Working Group of the EAHAD.

Dr. Roseline d’Oiron has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Biotest, CSL Behring, LFB, Novo Nordisk, Octopharma, Pfizer, Roche, Sobi and Takeda.